114 related articles for article (PubMed ID: 16619296)
1. Proteomics analysis of a novel compound: cyclic RGD in breast carcinoma cell line MCF-7.
Juan HF; Wang IH; Huang TC; Li JJ; Chen ST; Huang HC
Proteomics; 2006 May; 6(10):2991-3000. PubMed ID: 16619296
[TBL] [Abstract][Full Text] [Related]
2. An apoptosis-related gene network induced by novel compound-cRGD in human breast cancer cells.
Huang TC; Huang HC; Chang CC; Chang HY; Ou CH; Hsu CH; Chen ST; Juan HF
FEBS Lett; 2007 Jul; 581(18):3517-22. PubMed ID: 17624335
[TBL] [Abstract][Full Text] [Related]
3. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
[TBL] [Abstract][Full Text] [Related]
4. Integrin specificity of the cyclic Arg-Gly-Asp motif and its role in integrin-targeted gene transfer.
Wittekindt C; Böttger M; Höltje HD; Schäfer-Korting M; Cartier R; Haberland A
Biotechnol Appl Biochem; 2004 Dec; 40(Pt 3):281-90. PubMed ID: 14992694
[TBL] [Abstract][Full Text] [Related]
5. RGD peptides induce apoptosis by direct caspase-3 activation.
Buckley CD; Pilling D; Henriquez NV; Parsonage G; Threlfall K; Scheel-Toellner D; Simmons DL; Akbar AN; Lord JM; Salmon M
Nature; 1999 Feb; 397(6719):534-9. PubMed ID: 10028971
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery.
Bianchi A; Arosio D; Perego P; De Cesare M; Carenini N; Zaffaroni N; De Matteo M; Manzoni L
Org Biomol Chem; 2015 Jul; 13(27):7530-41. PubMed ID: 26074454
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proliferative and invasive capacities of breast cancer cells by arginine-glycine-aspartic acid peptide in vitro.
Yang W; Meng L; Wang H; Chen R; Wang R; Ma X; Xu G; Zhou J; Wang S; Lu Y; Ma D
Oncol Rep; 2006 Jan; 15(1):113-7. PubMed ID: 16328042
[TBL] [Abstract][Full Text] [Related]
8. Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas.
Amin M; Badiee A; Jaafari MR
Int J Pharm; 2013 Dec; 458(2):324-33. PubMed ID: 24148663
[TBL] [Abstract][Full Text] [Related]
9. Polymer-free immobilization of a cyclic RGD peptide on a nitinol stent promotes integrin-dependent endothelial coverage of strut surfaces.
Joner M; Cheng Q; Schönhofer-Merl S; Lopez M; Neubauer S; Mas-Moruno C; Laufer B; Kolodgie FD; Kessler H; Virmani R
J Biomed Mater Res B Appl Biomater; 2012 Apr; 100(3):637-45. PubMed ID: 22278946
[TBL] [Abstract][Full Text] [Related]
10. [Binding characteristics between RGD-containing cyclic peptide and rat hepatic stellate cells: an in vitro study].
Du SL; Wang JY; Lu WY
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):362-5. PubMed ID: 15918972
[TBL] [Abstract][Full Text] [Related]
11. A cyclic RGD-coated peptide nanoribbon as a selective intracellular nanocarrier.
Lim YB; Kwon OJ; Lee E; Kim PH; Yun CO; Lee M
Org Biomol Chem; 2008 Jun; 6(11):1944-8. PubMed ID: 18480908
[TBL] [Abstract][Full Text] [Related]
12. New potent and selective αvβ
Wu Z; Cheng X; Hong H; Zhao X; Zhou Z
Bioorg Med Chem Lett; 2017 May; 27(9):1911-1913. PubMed ID: 28351594
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Modified RGD-Based Peptides and Their in vitro Activity.
Hamdan F; Bigdeli Z; Asghari SM; Sadremomtaz A; Balalaie S
ChemMedChem; 2019 Jan; 14(2):282-288. PubMed ID: 30506622
[TBL] [Abstract][Full Text] [Related]
14. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
15. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.
Georgoulis A; Havaki S; Drosos Y; Goutas N; Vlachodimitropoulos D; Aleporou-Marinou V; Kittas C; Marinos E; Kouloukoussa M
Ultrastruct Pathol; 2012 Dec; 36(6):387-99. PubMed ID: 23181508
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
Chen X; Plasencia C; Hou Y; Neamati N
J Med Chem; 2005 Feb; 48(4):1098-106. PubMed ID: 15715477
[TBL] [Abstract][Full Text] [Related]
17. Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides.
Śmiłowicz D; Slootweg JC; Metzler-Nolte N
Mol Pharm; 2019 Nov; 16(11):4572-4581. PubMed ID: 31596097
[TBL] [Abstract][Full Text] [Related]
18. Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization.
Wang W; Wu Q; Pasuelo M; McMurray JS; Li C
Bioconjug Chem; 2005; 16(3):729-34. PubMed ID: 15898744
[TBL] [Abstract][Full Text] [Related]
19. Multimerization of cRGD peptides by click chemistry: synthetic strategies, chemical limitations, and influence on biological properties.
Wängler C; Maschauer S; Prante O; Schäfer M; Schirrmacher R; Bartenstein P; Eisenhut M; Wängler B
Chembiochem; 2010 Oct; 11(15):2168-81. PubMed ID: 20827791
[TBL] [Abstract][Full Text] [Related]
20. Cyclic RGD peptides with high affinity for alpha5beta1 integrin protect genetically fat Zucker rat livers from cold ischemia/reperfusion injury.
Fondevila C; Shen XD; Moore C; Busuttil RW; Coito AJ
Transplant Proc; 2005 May; 37(4):1679-81. PubMed ID: 15919428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
